Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord(TissueTech)(Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord(TissueTech))

概要

基本信息

药物类型

细胞疗法

别名

靶点-

作用机制

细胞替代物

治疗领域

神经系统疾病皮肤和肌肉骨骼疾病

在研适应症

关节痛

非在研适应症-

原研机构

BioTissue Holdings, Inc.

在研机构

BioTissue Holdings, Inc.

非在研机构-

最高研发阶段临床1期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

1

项与 Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord(TissueTech) 相关的临床试验

NCT06236308 / Not yet recruiting临床1期

A Randomized, Phase 1 Dose Finding Study of TTAX03 for the Treatment of Lumbosacral Facet Joint Pain

This is a pilot study examining the safety and efficacy of a single intra-articular (IA) injection of TTAX03 per joint to relieve severe spinal facet joint (FJ) pain and improve function in subjects with facet joint pain (FJP) in the lumbosacral region. The design is randomized, double blinded, placebo controlled and dose-group sequential.

开始日期2024-07-15

申办/合作机构

BioTissue Holdings, Inc.

100 项与 Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord(TissueTech) 相关的临床结果

登录后查看更多信息

100 项与 Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord(TissueTech) 相关的转化医学

登录后查看更多信息

100 项与 Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord(TissueTech) 相关的专利（医药）

登录后查看更多信息

100 项与 Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord(TissueTech) 相关的药物交易

登录后查看更多信息